Areas of relationship between immunology and clinical oncology.
D000230:Adenocarcinoma / Q000097:blood; D000486:Allergy and Immunology; D000818:Animals; D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002272:Carcinoembryonic Antigen / Q000032:analysis; D002822:Choriocarcinoma / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D005260:Female; D005326:Fetal Proteins / Q000032:analysis; D006801:Humans; D007049:Iatrogenic Disease; D007109:Immunity; D007165:Immunosuppression Therapy; D007938:Leukemia / Q000276:immunology; D008113:Liver Neoplasms / Q000097:blood; D008223:Lymphoma / Q000276:immunology; D008748:Methylcholanthrene; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics / Q000276:immunology* / Q000401:mortality; D009374:Neoplasms, Experimental / Q000139:chemically induced; D011247:Pregnancy; D011379:Prognosis; D014181:Transplantation Immunology
D000951:Antigens, Neoplasm; D000970:Antineoplastic Agents; D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D005326:Fetal Proteins; D008748:Methylcholanthrene